who reports todayUS earnings, drawn as flowsMy portfolio

← Who reports today · Health Care

How CVS Health (CVS) makes money: Q3 2026 revenue breakdown

US GAAP, Q3 2026 · quarter ended 09/30/2026 · released Nov 4

Net income (loss) attributable to CVS Health

$2,172M

Total revenues

$108,399M

up 5.4% y/y

Operating income (loss)

$3,566M

Next report

~ Feb 9

not announced yet

The quarter in brief

Revenue $108.40B (+5.4% y⁠/⁠y), operating income $3.57B, net income $2.17B.

Key growth driver: Products — the fastest-growing revenue line: $69,225, +7% y/y. · by the Q3 2026 report

How does CVS Health make money?

CVS Health brought in $108 billion of revenue in Q3 2026, up 5.4% year over year. The largest source was Products: $69.2 billion, or 64% of the total, followed by Premiums ($34.6B, 32%) and Services ($3.96B, 4%); other lines add the remaining 0.6%. Net income for the quarter was $2.17 billion.

Revenue by source, Q3 2026
  • Products$69.2B · 64% · +7.2%
  • Premiums$34.6B · 32% · +2.5%
  • Services$3.96B · 4% · +0.8%
  • Net investment income$647M · 0.6% · +2.4%

Shares of $108B total revenue; changes are year over year, as reported. ≈ marks lines derived from disclosed totals. The same flows are drawn in the Sankey chart below.

All figures in $M.

Sankey diagram of CVS (CVS Health) earnings report for Q3 2026: revenue, costs and profitProducts$69,225 · +7.2%Premiums$34,566 · +2.5%Services$3,961 · +0.8%Net investment income$647 · +2.4%Total revenues$108,399 · +5.4%Cost of productssold$61,185 · +7.3%Health care costs$32,316 · +0.9%Operatingexpenses$11,332 · +0.4%Operating income(loss)$3,566 · vs −$3,2073.3% marginInterest expense$747 · −4.7%Other income$30 · +15.4%Income (loss)before income taxprovision$2,849 · vs −$3,482Income tax provision$678 · +33.5%23.8% effective rateNet (income) lossattributable tononcontrolling interests$1 · −93.3%Net income (loss)attributable to CVS Health$2,172 · vs −$3,975$1.68/sh · 2.0% margin
Sankey diagram of CVS (CVS Health) earnings report for Q3 2026: revenue, costs and profit
Line itemAmount and change
Products$69,225 · +7.2%
Premiums$34,566 · +2.5%
Services$3,961 · +0.8%
Net investment income$647 · +2.4%
Total revenues$108,399 · +5.4%
Cost of products sold$61,185 · +7.3%
Health care costs$32,316 · +0.9%
Operating expenses$11,332 · +0.4%
Operating income (loss)$3,566 · vs −$3,207 · 3.3% margin
Interest expense$747 · −4.7%
Other income$30 · +15.4%
Income (loss) before income tax provision$2,849 · vs −$3,482
Income tax provision$678 · +33.5% · 23.8% effective rate
Net (income) loss attributable to noncontrolling interests$1 · −93.3%
Net income (loss) attributable to CVS Health$2,172 · vs −$3,975 · $1.68/sh · 2.0% margin

Verdict: revenue $108.40B (+5.4% y/y), operating income $3.57B, net income $2.17B.

CVS raised its full-year 2026 GAAP diluted EPS guidance to at least $6.98 from a range of $6.84 to $7.04, and its adjusted EPS guidance to at least $8.20 from $7.90 to $8.10. Full-year 2026 total revenues are projected at at least $420.0 billion. Cash flow from operations guidance was raised to at least $15.5 billion from at least $11.5 billion, after $15.3 billion was generated year to date. Dividends paid in the first nine months totaled $2,578 million.

Source and notation

Source: CVS Health earnings release, 8-K EX-99 of 11/04/2026 (SEC EDGAR).

Open as an image: CVS Health (CVS), Q3 2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0

Cite / embed this chart

Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).

Credit line
Chart: “CVS Health (CVS) Q3 2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/cvs. Licensed under CC BY 4.0.
HTML: image with link and credit
<figure>
  <a href="https://whoreportstoday.com/t/cvs"><img src="https://whoreportstoday.com/t/cvs/img/cvs-health-earnings-sankey.png" alt="CVS Health (CVS) Q3 2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a>
  <figcaption>Source: <a href="https://whoreportstoday.com/t/cvs">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption>
</figure>
Direct link to the image (PNG)
https://whoreportstoday.com/t/cvs/img/cvs-health-earnings-sankey.png
Link for your article text
<a href="https://whoreportstoday.com/t/cvs">CVS Health (CVS) Q3 2026 earnings chart (Who Reports Today)</a>

The image link always shows the latest report’s chart and will update with the next quarter. To keep this exact chart in your article, save the PNG and upload it yourself — the license allows that. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.

CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. · Text: Wikipedia, CC BY-SA 4.0, abridged

The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores.

Company reports

Q3 2026latest breakdownRevenue $108.40B (+5.4% y/y), operating income $3.57B, net income $2.17B.
Q2 2026A strong quarter for CVS as revenue grew 7.3% on gains across all three segments and net income attributable to CVS…

Company guidance

Same quarter a year ago (ended December 31, 2025): revenue $105.7B, EPS (GAAP) $2.31

How we calculate

Year-ago figures are GAAP, from the company's SEC filings (XBRL); EPS is diluted.

CVS earnings history: past report dates

Nov 4, 2026 Wed6:31 ambefore market openSep 30, 2026$108B+5% y/y$1.68
Aug 5, 2026 Wed6:32 ambefore market openJun 30, 2026$106B+7% y/y$2.31+189% y/y
May 6, 2026 Wed6:31 ambefore market openMar 31, 2026$100B+6% y/y$2.30+63% y/y
Feb 10, 2026 Tue6:31 ambefore market openDec 31, 2025≈$106B+8% y/y≈$2.31+78% y/y
Oct 29, 2025 Wed6:32 ambefore market openSep 30, 2025$103B+8% y/y−$3.13
Jul 31, 2025 Thu6:31 ambefore market openJun 30, 2025$98.9B+8% y/y$0.80−43% y/y
May 1, 2025 Thu6:32 ambefore market openMar 31, 2025$94.6B+7% y/y$1.41+60% y/y
Feb 12, 2025 Wed6:32 ambefore market openDec 31, 2024≈$97.7B+4% y/y≈$1.30−18% y/y
Nov 6, 2024 Wed6:33 ambefore market openSep 30, 2024$95.4B+6% y/y$0.07−96% y/y
Aug 7, 2024 Wed6:33 ambefore market openJun 30, 2024$91.2B+3% y/y$1.41−5% y/y
May 1, 2024 Wed6:32 ambefore market openMar 31, 2024$88.4B+4% y/y$0.88−47% y/y
Feb 7, 2024 Wed6:33 ambefore market openDec 31, 2023≈$93.8B+12% y/y≈$1.59−10% y/y
Nov 1, 2023 Wed6:35 ambefore market openSep 30, 2023$89.8B+11% y/y$1.75
Aug 2, 2023 Wed6:34 ambefore market openJun 30, 2023$88.9B+10% y/y$1.48−35% y/y
May 3, 2023 Wed6:34 ambefore market openMar 31, 2023$85.3B+11% y/y$1.65−7% y/y
Feb 8, 2023 Wed6:32 ambefore market openDec 31, 2022≈$83.8B+9% y/y≈$1.77+70% y/y
Show all 16 reports since 2023Show fewer
How we count

Report date and time — when the company filed its results press release with the SEC (Form 8-K, Item 2.02); the regular session runs 9:30 am – 4:00 pm ET. Companies that file the 8-K late in the evening publish the release the next morning: the date is that morning, before market open, and the evening filing time is not shown. Revenue and diluted EPS — the company’s XBRL filings, EPS adjusted for stock splits; ≈ — fourth quarter derived as full year minus three quarters. Source: SEC EDGAR.

CVS Health: 15-year financials

2025402,0674,6601,7687,8073,397
2024372,8098,5164,6146,3263,373
2023357,77613,7438,34410,3953,132
2022322,4677,9544,31113,4502,907
2021292,11113,3108,00115,7452,625
2020268,70613,9117,17913,4282,624
2019256,77611,9876,63410,3912,603
2018194,5794,021−5946,8282,038
2017184,7869,5386,6226,0892,049
2016177,54610,3865,3177,9171,840
2015153,2909,4755,2376,1721,576
2014139,3678,7994,6446,0011,288
2013126,7618,0374,5923,7991,097
2012123,1207,2103,8644,641829
2011107,0806,3313,4623,984674

$ millions, annual 10-K reports on SEC EDGAR (US GAAP)*.

* Sources
How we calculate

Figures are annual report lines; if a year was later restated (discontinued operations, mergers), we use the latest filing that shows it. Free cash flow is operating cash flow minus capital expenditures; dividends are cash paid to common shareholders during the year. “—” means the line isn’t in the filing. The table starts in 2011; where the listed issuer changed (holding reorganization, redomicile), earlier years come from the predecessor’s filings.

CVS Health: 15-year balance sheet

YearAssetsEquityDebtCashCurrent assetsCurrent liabilities
2025253,53875,21464,5708,45374,71488,692
2024253,21575,56066,2708,58668,64584,609
2023249,72876,46161,6108,19667,85879,189
2022228,27571,46952,25412,94565,63369,421
2021232,99975,07556,1769,40860,00867,807
2020230,71569,38964,6477,85456,36962,017
2019222,44963,86468,4805,68350,30253,303
2018196,45658,22574,1494,05945,24344,009
201795,13137,69128,2781,69631,22930,648
201694,46236,83027,5743,37131,04226,250
201592,43737,19627,5002,45929,15823,169
201474,18737,95812,9852,48125,98319,027
201371,52637,93813,4004,08925,32515,425
201266,22137,6539,7901,37520,16114,150
201164,85238,01310,0501,41318,59411,956

$ millions, at fiscal year-end*.

* Sources
How we calculate

Annual balance sheet figures. “—” means no data; zero appears only when a numeric zero is present. Metrics with fewer than two values are omitted. Annual amounts use the financial screener data, in the reporting currency. Equity is attributable to shareholders where available, otherwise total equity including noncontrolling interests. Debt and cash follow the stored figures: they may include leases and restricted cash. Snapshot updated: .

Cash flow

9 months ended 2026-09-30 · $M

LineThis periodYear agoΔ
Operating cash flowcash the business generated15,3187,249+8,069
· incl. D&A (non-cash add-back)depreciation & amortization3,3733,459
· incl. stock-based comp (non-cash)share-based compensation610400
Capexpurchases of property & equipment−2,357−2,048−309
Free cash flow ≈operating cash flow − capex12,9615,201+7,760
Investing activities, netcapex, acquisitions, securities−5,545−3,873−1,672
· incl. acquisitionsbusinesses net of cash acquired−15−429+414
Financing activities, netdebt, buybacks, dividends−6,537−2,908−3,629
· incl. buybacksrepurchases of common stock—0
· incl. dividends paid−2,578−2,552−26
Net change in cash3,236468+2,768
How to read the table

Cash flow is cumulative from the start of the fiscal year, rather than a single quarter. Lines marked ≈ are derived. Green Δ means more cash in (or less out) than a year ago. ≈ in Δ means a difference that rounds to zero at the displayed precision.

Shareholders’ equity at Sep 30, 2026: $80.5B (31% of total assets). Compare with other S&P 500 companies →

Corporate governance

2/2good

  • Feb 20262025 10-K cover: a single class — Common Stock, $0.01 (NYSE: CVS). sec.gov ↗
  • Feb 2026Diluted share count −3.3% over 2020–2025; SBC of $535M = 0.1% of $402B revenue (XBRL). data.sec.gov ↗
2 more facts and scoring

How the company treats minority shareholders: 2 — well, 0 — systematically poorly.

  • Feb 2026Per-share dividend: $2.00 in 2017–2021, $2.20 in 2022, $2.42 in 2023, $2.66 in 2024–2025 — no cuts (XBRL). data.sec.gov ↗
  • Feb 2026The 2019 class actions over the LTC business were dismissed by the courts (the last in Feb. 2025, under appeal); the 2024 suits over insurance-segment profitability are unresolved. sec.gov ↗

Scoring: 2.0 with no deductions = 2.0 (single share class, shares −3.3% over 5 years, dividend never cut, 2019 class actions dismissed by the court, 2024 suits unresolved)

Share classes
Single class of common stock (10-K cover: Common Stock, NYSE).
Dilution
Diluted shares −3.3% over 2020–2025, SBC 0.1% of revenue; buybacks of $8.5B over 2022–2024.
Disclosure
Full 10-K/10-Q reporting.
Dividends
$2.00 per share frozen in 2018–2021 (deleveraging after the Aetna acquisition), then $2.20 → $2.66; no cuts.
Lawsuits & regulators
2019 suits (LTC/Omnicare): City of Miami — dismissed (affirmed by the 1st Circuit in 2022), City of Warren — dismissed 2023, Waterford — dismissed 2025 (on appeal); 2024 suits (Louisiana Sheriffs, SDNY) — at the motion stage, unresolved → no deduction. Opioid settlements are industry-wide, not a criterion.
Related parties
No material related-party transactions in the 2026 proxy.

How the score works · checked as of Oct 2026

Included in screener lists: S&P 500 companies with revenue growth 10 years in a row · S&P 500 companies that paid dividends 10 years without a gap

CVS Health (CVS) earnings: FAQ

How does CVS Health make money?

CVS Health brought in $108 billion of revenue in Q3 2026, up 5.4% year over year. The largest source was Products: $69.2 billion, or 64% of the total, followed by Premiums ($34.6B, 32%) and Services ($3.96B, 4%); other lines add the remaining 0.6%. Net income for the quarter was $2.17 billion.

When is CVS's next earnings date?

We have not yet seen an announcement of the date from CVS Health (CVS). Based on last year's report on Feb 10, 2026, the next report is expected around Feb 9, 2027.

What time does CVS report earnings?

CVS Health usually reports before market open: its latest results release was filed with the SEC at 6:31 am ET on Nov 4, 2026.

When did CVS last report earnings?

CVS Health reported Q3 2026 results on Nov 4, 2026.

Where can I find CVS Health's financial statements?

On SEC EDGAR: quarterly reports (10-Q), the annual report (10-K) and earnings releases (8-K). The “Verified” badge next to the chart links to CVS's filings; this page breaks the latest report down in a Sankey chart.

What was CVS's net income in Q3 2026?

CVS Health reported net income of $2,172M for Q3 2026 (vs −$3,975 year over year), under US GAAP.

Does CVS Health pay dividends?

Yes. In 2025, CVS Health paid $3,397M in dividends on its common stock, per its 10-K. Earlier years are in the 15-year table above.

How has CVS Health's revenue changed since 2011?

Per its 10-K filings, revenue grew 3.8x: $107,080M in 2011 and $402,067M in 2025. The latest year is the highest in the table. Year-by-year figures are in the table above.

New to earnings reports? Start with how to read an earnings report.

Get it every Monday: who reports this week

Once a week: companies that announced report dates for the week ahead (US and Canada), fresh report breakdowns with charts. Free, no account needed.

Only dates announced by companies. No stock prices. Not investment advice.

More reports: DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · ELV · Q3 2026 · EW · Q2 2026 · GEHC · Q3 2026 · GILD · Q3 2026 · HCA · Q3 2026 · HSIC · Q3 2026 · all reports

Cookies the site needs and, with your consent, Google Analytics — privacy policy